Diagnostics | Why diagnostics are a gamechanger to control a pandemic and what this means for combatting AMR
Moderator and Speaker: Sergio Carmona, Chief Access Officer, FIND
This content has been restricted to logged in users only. Please login to view this content.
Speakers:
- Rosanna Peeling – Professor and Chair, Diagnostics Research & Director, International Diagnostics Centre, London School of Hygiene & Tropical Medicine
This content has been restricted to logged in users only. Please login to view this content.
- Claudia Denkinger – Head of Division of Tropical Medicine, University Hospital Heidelberg
This content has been restricted to logged in users only. Please login to view this content.
- Stefanie Deinhardt-Emmer – a clinical expert from University Clinic of Jena, Germany
This content has been restricted to logged in users only. Please login to view this content.
- Joe Fitchett – Medical Director, Mologic
This content has been restricted to logged in users only. Please login to view this content.
Play Video
This might also be of interest for you:
- The Lancet, 1 August, Rosanna Peeling et al: Diagnostics in the response to antimicrobial resistance
- Overview of Antimicrobial Resistance Programme, FIND
- News release, 26 June, LSHTM: TB cases and deaths predicted to spike due to COVID-19
- News release, 3 June, Mologic: Mologic CE Marks professional-use rapid diagnostic test for COVID-19 and begins manufacture
- Infectognostics Research Campus Jena in the AMR Stakeholder Guide
